Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
CSL Behring will close California office as part of shrinking ex vivo work
6 months ago
Cell/Gene Tx
Adaptimmune to 'redefine' itself as a sarcoma biotech, cuts a third of staffers
6 months ago
R&D
Pharma
Trump picks vaccine skeptic Kennedy to lead HHS, in what would be an upheaval of US health policy
6 months ago
Pharma
FDA+
Gilead will close Philadelphia, Seattle offices as part of job reductions
6 months ago
Pharma
Cell/Gene Tx
Exclusive: Ascidian CEO Michael Ehlers leaves Apple Tree Partners for MPM BioImpact
6 months ago
Startups
Exclusive: Flagship names two CEO-partners to lead Valo Health, Apriori Bio
6 months ago
Startups
Thermo Fisher consolidates viral vector work in Massachusetts, cuts 160 workers
6 months ago
Manufacturing
Senior AstraZeneca exec detained in China amid wider investigation
6 months ago
China
Pharma
Q&A: Demis Hassabis talks winning the Nobel Prize, building an AI biotech sans lab, and Trump’s potential impact
6 months ago
AI
Moderna reports slow start to RSV sales as Bancel steps back from commercial role
6 months ago
Pharma
GSK CEO Emma Walmsley on the new Trump administration, trust, AI and China
6 months ago
China
AI
CVS names Aetna head, plans more pharmacy closures as new CEO takes over
6 months ago
Pharma
Health Tech
Exclusive: Women’s health unicorn Maven Clinic cuts 10% of its workforce weeks after raising $125M
6 months ago
Health Tech
Elucida Oncology, seeking foothold in ADCs, shutters due to 'lack of funding'
7 months ago
Startups
Apertura and Atalanta reduce headcount en route toward the clinic
7 months ago
Cell/Gene Tx
A conversation with Nobel Prize winner David Baker on the future of AI in protein design — and beyond
7 months ago
R&D
AI
CVS replaces CEO Karen Lynch with PBM exec David Joyner
7 months ago
Health Tech
RNA gene therapy startup Shape hunts for new CEO as Series C awaits
7 months ago
Startups
Cell/Gene Tx
BenevolentAI CEO is out after less than a year on the job
7 months ago
AI
Sage shakes up senior management, slashes pipeline, sheds 33% of staff
7 months ago
R&D
Mark Pruzanski gets another shot at MASH, joining as chair of Inventiva as it gets ‘much-needed funding’
7 months ago
Financing
Stealth BioTherapeutics CEO discusses surprise adcomm support for ultra-rare disease drug
7 months ago
FDA+
Turnstone rejigs staff and exec team, eases preclinical work as cash runs low
7 months ago
R&D
Exclusive: How an accidental email tipped Pfizer off to an activist investor’s plan
7 months ago
Pharma
First page
Previous page
4
5
6
7
8
9
10
Next page
Last page